Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant post-operative therapy

K Leiper1, I London, J M Rhodes

  • 1Department of Medicine, University of Liverpool, UK.

Bailliere'S Clinical Gastroenterology
|August 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis.

Journal of internal medicine·2020
Same author

Food additives: Assessing the impact of exposure to permitted emulsifiers on bowel and metabolic health - introducing the FADiets study.

Nutrition bulletin·2019
Same author

A drunk and disorderly country: a nationwide cross-sectional survey of alcohol use and misuse in Great Britain.

Frontline gastroenterology·2017
Same author

Dietary exposure to emulsifiers and detergents and the prevalence of cardiovascular disease.

QJM : monthly journal of the Association of Physicians·2017
Same author

MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis.

Cell death & disease·2014
Same author

Studies on the in vitro incorporation of carbon-14 labelled glycine into haemoglobin by immature red cells.

Progress in nuclear energy. Series 6 Biological sciences·2014
Same journal

Index.

Bailliere's clinical gastroenterology·2020
Same journal

Home enteral and parenteral nutrition in children.

Bailliere's clinical gastroenterology·1999
Same journal

Nutritional support in malnourished paediatric patients.

Bailliere's clinical gastroenterology·1999
Same journal

Cholestasis and end-stage liver disease.

Bailliere's clinical gastroenterology·1999
Same journal

Cystic fibrosis: nutritional consequences and management.

Bailliere's clinical gastroenterology·1999
Same journal

Pancreatic diseases (excluding cystic fibrosis).

Bailliere's clinical gastroenterology·1999
See all related articles

For Crohn's disease patients undergoing surgery, stopping smoking is crucial. A short course of metronidazole and continued mesalazine may help reduce relapse rates, though further research is needed.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Clinical Pharmacology

Background:

  • Crohn's disease frequently necessitates surgery, yet post-operative recurrence rates are high, affecting approximately 50% within five years.
  • Endoscopic signs of relapse are detectable in a significant majority of patients shortly after resection, highlighting a critical unmet need.
  • Identifying effective strategies to mitigate post-surgical recurrence is paramount for improving long-term patient outcomes.

Purpose of the Study:

  • To review and synthesize current evidence on factors influencing Crohn's disease recurrence post-surgery.
  • To evaluate the efficacy of various interventions, including lifestyle modifications and pharmacotherapies, in preventing post-operative relapse.
  • To provide evidence-based recommendations for managing patients after Crohn's disease surgery.

Related Experiment Videos

Main Methods:

  • Systematic review of retrospective studies and clinical trials concerning post-operative Crohn's disease management.
  • Analysis of data on the impact of smoking cessation, dietary interventions, and specific medications on disease recurrence.
  • Evaluation of evidence for drugs such as mesalazine, metronidazole, azathioprine, and budesonide.

Main Results:

  • Smoking cessation is strongly associated with a better prognosis after surgery.
  • Metronidazole (20 mg/day for 3 months) demonstrated a sustained reduction in relapse rates (over one-third) for up to three years.
  • Mesalazine showed a modest benefit in meta-analyses, but recent large trials yielded inconclusive results. Corticosteroids like budesonide were not superior to placebo for maintenance therapy.

Conclusions:

  • Strongly advise patients with Crohn's disease to cease smoking to improve surgical outcomes.
  • A 3-month course of metronidazole combined with maintenance mesalazine is justifiable based on current evidence for preventing post-operative recurrence.
  • Further research is required to optimize dosages and confirm the long-term efficacy and safety of these interventions, particularly for metronidazole to address potential neuropathy.